Catalyst
Slingshot members are tracking this event:
Arrowhead (ARWR) Has Regulatory Submissions Planned for Phase 1/2 Trial Evaluating ARC-521 in Hepatitis-B by End of Q2 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARWR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 28, 2016
Occurred Source:
http://ir.arrowheadpharma.com/releasedetail.cfm?ReleaseID=967823
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Regulatory Submissions
